| 前收市價 | 45.27 |
| 開市 | 48.27 |
| 買盤 | 50.15 x 1800 |
| 賣出價 | 50.23 x 1100 |
| 今日波幅 | 47.73 - 50.61 |
| 52 週波幅 | 39.35 - 63.41 |
| 成交量 | |
| 平均成交量 | 15,512,495 |
| 市值 | 102.267B |
| Beta 值 (5 年，每月) | 0.44 |
| 市盈率 (最近 12 個月) | 無 |
| 每股盈利 (最近 12 個月) | -3.10 |
| 業績公佈日 | 2024年7月26日 |
| 遠期股息及收益率 | 2.40 (5.30%) |
| 除息日 | 2024年7月05日 |
| 1 年預測目標價 | 49.29 |
Investor's Business DailyBristol Myers Retakes Its 200-Day Line On Quarterly Beat, Surprise Immunology Win
Bristol Myers Squibb stock gapped higher Friday after the Big Pharma stalwart beat June-quarter forecasts and raised its outlook.
Barrons.comThese Stocks Moved the Most Today: DexCom, 3M, Nvidia, Bristol Myers, Coursera, Biogen, Charter, Deckers, and More
Stocks rose sharply Friday after the personal consumption expenditures price index, the report the Federal Reserve considers the most accurate measure of price inflation, matched expectations. The data have analysts and economists expecting an interest-rate cut from the Fed in September.
Motley FoolWhy Bristol Myers Squibb Jumped Nearly 10% on Friday
The pharmaceutical company is faring far better than most investors were anticipating at this point.
